Spinal circuitry for ventilatory control and compensation

用于通气控制和补偿的脊髓回路

基本信息

批准号：
10397050
负责人：
STEVEN ALLEN CRONE
金额：
$ 34.78万
依托单位：
CINCINNATI CHILDRENS HOSP MED CTR
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-05-01 至 2024-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10397050
关键词：
ALS patients Amyotrophic Lateral Sclerosis Atelectasis Behavior Brain Stem Breathing Cause of Death Cervical Chest Chronic Communication impairment Data Disease Disease Progression Electromyography Exercise Failure Financial compensation Foundations Functional disorder Glutamates Goals Health Impairment Injury Lateral Lead Life Location Lumbar spinal cord structure Measurement Mechanical ventilation Medial Molecular Molecular Profiling Motor Motor Neurons Mus Muscle Muscle function Nerve Degeneration Neuromuscular Diseases Neurons Patients Pattern Pharmacology Play Prevention Rabies virus Respiration Disorders Respiratory Diaphragm Respiratory Failure Respiratory Muscles Respiratory Tract Infections Rest Role Signal Pathway Sleep Spinal Spinal Cord Spinal cord injury Testing Therapeutic Transgenic Organisms Viral Work cost designer receptors exclusively activated by designer drugs experimental study hazard improved mad itch virus molecular subtypes motor neuron degeneration mouse model neural circuit neuroregulation novel strategies premature prevent recruit respiratory therapy development ventilation

项目摘要

Crone, S. A. Project Summary The proposed studies investigate the role of spinal V2a neurons in the control of auxiliary (non- diaphragmatic) respiratory muscles (ARMs) for inspiration. These muscles are normally used to increase ventilation during exercise, but they are also used to augment diaphragm function after injury or disease. Despite the importance of ARMs for enhancing ventilation or compensating for loss of diaphragm function, little is known about the neural circuits that drive their activity in either health or disease. ARM activity increases ventilation in ALS model mice at early disease stages, but there is a central deficit that prevents activation of ARMs for breathing at late disease stages, despite the fact that these muscles are active and functional for voluntary behaviors. Either increasing (through Gq signaling pathways) or decreasing (through Gi signaling pathways) the excitability of V2a neurons is able to increase ARM activity at rest in healthy and ALS model mice. Thus, these neurons are a potential target to increase ARM activity and ventilation in patients with ALS, other neuromuscular diseases, or spinal cord injury. However, the V2a class of neurons appears to be composed of subtypes that play distinct roles in the control of breathing. In order to develop therapies to improve breathing by altering the activity, preventing degeneration, or replacing degenerated V2a neurons, it is necessary to determine the location and molecular subtypes of V2a neurons that impact ventilation and to understand their specific roles. Aim 1 will use transgenic and viral strategies to increase excitability, decrease excitability, or ablate V2a neurons in cervical, thoracic, or lumbar spinal cord to identify how respiratory muscle activity is regulated by V2a neurons at different segmental levels. Aim 2 will investigate the molecular diversity of V2a neurons within the cervical cord by investigating differences in connectivity and function within respiratory circuits of a medial V2a subtype and a lateral V2a subtype. Aim 2 will also asses the effects on ventilation of altering excitability of only V2a neurons with direct excitatory connections to respiratory motor neurons. Aim 3 will assess the long- term impact that degeneration of V2a neurons has on breathing by prematurely ablating cervical V2a neurons in a mouse model of ALS. The potential benefit (and hazards) of chronically increasing the excitability of V2a neurons on ARM activity, motor neuron degeneration, and ventilatory health in ALS model mice will also be assessed. By accomplishing these aims, we will pinpoint the location, molecular identity, and connectivity of spinal V2a neurons that pattern respiratory muscle activity as well as assess the potential of pharmacologically altering the excitability of V2a neurons to improve breathing in a mouse model of ALS.